MedPAC examines Medicare quality measurement, drug spending
At this week, the Medicare Payment Advisory Commission discussed a wide range of quality-related topics, including measures for long-stay nursing facility residents, behavioral health care and the Medicare program, and reforming quality measurement implications for premium support. Commissioners also examined six proposals MedPAC staff believe have the potential to slow the rate of growth of pharmaceutical spending by Medicare. These options seek to increase price competition, address Part B drug price growth and improve the current payment formula and data. Commissioners also received a status report on Medicare Accountable Care Organizations. The commission will meet again in November.
Related News Articles
Headline
The AHA May 15 urged the Federal Emergency Management Agency Review Council to immediately act on expediting the processing of applications, reimbursement of…
Headline
The Departments of Labor, Health and Human Services, and the Treasury May 15 announced that they will not enforce the 2024 mental health parity final rule, a…
Headline
The Centers for Medicare & Medicaid Services May 12 released draft guidance for the third round of negotiations for the Medicare Drug Price Negotiation…
Headline
The AHA May 14 filed an amicus brief in the U.S. District Court for the District of South Dakota in defense of the state’s 340B contract pharmacy law…
Headline
The Senate May 15 unanimously passed a bipartisan resolution recognizing National Hospital Week, May 11-17. The resolution was sponsored by Sens. John Barrasso…
Headline
Overdose deaths in the U.S. fell 26.9% last year to 80,391, according to estimates from the Centers for Disease Control and Prevention. The agency reported…